Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Immuno Cure Acquires Partner Teresa Healthcare, an Electroporation Company

publication date: Sep 20, 2022

Immuno Cure, a Hong Kong biotech focused on DNA vaccines and immunotherapies, acquired 92.6% of Shanghai Teresa Healthcare, an electroporation company. Teresa’s EP device delivers brief electrical pulses to improve penetration of DNA vaccines through cell membranes to increase gene expression and immune responses. Immuno Cure already uses Teresa’s technology to deliver its two PD-1-Enhanced DNA vaccines, currently in clinical trials. Immuno Cure will pay for most of the transaction in cash. Teresa shareholders will also receive 1.5% equity in Immuno Cure, and the inventor of Teresa's EP technology, Professor Yuhong Xu, will continue to own her 7.4% stake in Teresa. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here